ASIX Spending and interest coverage

AdvanSix Inc. (ASIX) Spending and interest coverage

R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

Metric	Value	Formula and calculation
R&D / revenue · 12 months	(m)	Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m).
Stock-based compensation / revenue · 12 months	(m)	Share-based compensation / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m).
Interest coverage · 12 months	(m)	Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m).

Calculation inputs

Input	Amount with unit	Raw financial data
Research and development spending	(m)	Research and Development Expense
Revenue	(m)	Revenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation	6.41M USD	Share-based Payment Arrangement, Noncash Expense
Operating income	(m)
Interest expense · reported / estimated	(m)	· Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period ending	Research and development spending (USD)	Revenue (USD)	Stock-based compensation (USD)	Operating income (USD)	Interest expense · reported / estimated (USD)	R&D / revenue	SBC / revenue	Interest coverage	Interest expense basis
2026-06-30	(m)	(m)	$6.41M	(m)	(m)	(m)	(m)	(m)	(m)
2026-03-31	(m)	(m)	$6.89M	(m)	(m)	(m)	(m)	(m)	(m)
2025-12-31	$8.70M	(m)	$6.82M	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	(m)	(m)	$7.81M	(m)	(m)	(m)	(m)	(m)	(m)
2025-06-30	(m)	(m)	$7.74M	(m)	(m)	(m)	(m)	(m)	(m)
2025-03-31	(m)	(m)	$7.62M	(m)	(m)	(m)	(m)	(m)	(m)
2024-12-31	$8.80M	(m)	$7.85M	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	(m)	(m)	$8.44M	(m)	(m)	(m)	(m)	(m)	(m)
2024-06-30	(m)	(m)	$8.27M	(m)	(m)	(m)	(m)	(m)	(m)
2024-03-31	(m)	(m)	$8.51M	(m)	(m)	(m)	(m)	(m)	(m)
2023-12-31	$9.80M	(m)	$8.31M	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	(m)	(m)	$8.52M	(m)	(m)	(m)	(m)	(m)	(m)
2023-06-30	(m)	(m)	$9.35M	(m)	(m)	(m)	(m)	(m)	(m)
2023-03-31	(m)	(m)	$8.92M	(m)	(m)	(m)	(m)	(m)	(m)
2022-12-31	$12.50M	(m)	$10.28M	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	(m)	(m)	$10.29M	(m)	(m)	(m)	(m)	(m)	(m)
2022-06-30	(m)	(m)	$10.57M	(m)	(m)	(m)	(m)	(m)	(m)
2022-03-31	(m)	(m)	$12.31M	(m)	(m)	(m)	(m)	(m)	(m)
2021-12-31	$14.00M	$1.68B	$11.30M	(m)	(m)	0.83%	0.67%	(m)	(m)
2021-09-30	(m)	(m)	$10.01M	(m)	(m)	(m)	(m)	(m)	(m)
2021-06-30	(m)	(m)	$8.11M	(m)	(m)	(m)	(m)	(m)	(m)
2021-03-31	(m)	(m)	$6.07M	(m)	(m)	(m)	(m)	(m)	(m)
2020-12-31	$11.80M	$1.16B	$4.90M	(m)	(m)	1.02%	0.42%	(m)	(m)
2020-09-30	(m)	(m)	$4.28M	(m)	(m)	(m)	(m)	(m)	(m)
2020-06-30	(m)	(m)	$5.67M	(m)	(m)	(m)	(m)	(m)	(m)
2020-03-31	(m)	(m)	$6.79M	(m)	(m)	(m)	(m)	(m)	(m)
2019-12-31	$13.90M	$1.30B	$8.35M	(m)	(m)	1.07%	0.64%	(m)	(m)
2019-09-30	(m)	(m)	$10.20M	(m)	(m)	(m)	(m)	(m)	(m)
2019-06-30	(m)	(m)	$10.82M	(m)	(m)	(m)	(m)	(m)	(m)
2019-03-31	(m)	(m)	$10.61M	(m)	(m)	(m)	(m)	(m)	(m)
2018-12-31	$14.80M	(m)	$10.13M	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	(m)	(m)	$9.56M	(m)	(m)	(m)	(m)	(m)	(m)
2018-06-30	(m)	(m)	$9.00M	(m)	(m)	(m)	(m)	(m)	(m)
2018-03-31	(m)	$1.46B	$8.34M	(m)	(m)	(m)	0.57%	(m)	(m)
2017-12-31	$12.91M	$1.48B	$7.74M	(m)	(m)	0.88%	0.52%	(m)	(m)
2017-09-30	(m)	$1.36B	$7.01M	(m)	(m)	(m)	0.51%	(m)	(m)
2017-06-30	(m)	$1.32B	$4.95M	(m)	(m)	(m)	0.37%	(m)	(m)
2017-03-31	(m)	$1.27B	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-12-31	$13.76M	$1.19B	$1.33M	(m)	(m)	1.15%	0.11%	(m)	(m)
2016-09-30	(m)	$1.25B	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-06-30	(m)	$1.26B	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-12-31	$12.81M	$1.33B	(m)	(m)	(m)	0.96%	(m)	(m)	(m)
2014-12-31	$13.00M	$1.79B	(m)	(m)	(m)	0.73%	(m)	(m)	(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
PureCycle Technologies, Inc. (PCT)	United States	$0.975B	-7.32
ROGERS CORP (ROG)	United States	$2.435B	-34.15
AVIENT CORP (AVNT)	United States	$3.739B	19.95
HEXCEL CORP /DE/ (HXL)	United States	$6.464B	49.18
EASTMAN CHEMICAL CO (EMN)	United States	$7.575B	17.34
ALBEMARLE CORP (ALB)	United States	$12.778B	71.05
DuPont de Nemours, Inc. (DD)	United States	$17.580B	1,010.90
DOW INC. (DOW)	United States	$20.577B	-11.55